A COPD Screening Shift Could Bring Better Therapies
A re-prioritization of disease monitoring and screening could help physicians better understand how one of the greatest killers in the US could be combated.
Related Articles
IgA Nephropathy
The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and…
The Medical Sisterhood: LEADderm & The Power of the Podium, with Jennifer Soung, MD
Jennifer Soung, MD, joins The Medical Sisterhood to discuss her journey to launching LEADderm and how owning the podium has changed her career.
Combination of Statins, Ezetimibe Could Prevent Thousands of Heart Attacks
Individuals treated with ezetimibe shortly after myocardial infarction experience an improved prognosis versus those who receive delayed treatment or none at all.
Scaling Health Equity in Heart Failure, With Anita Radhakrishnan, MD
Radhakrishnan describes a unique initiative in Pittsburgh promoting health equity and closing the gap in cardiovascular health disparities.
Binge Drinking Rates Increasing Among Young Female Adults, Study Finds
Past month binge drinking rates were greater among females 18-25 years of age than males from 2021-2023, reversing trends seen from 2017-2019.
Mixed Type 1/3 Inflammation Linked to Faster Polyp Recurrence in CRSwNP
A new study identified 6 distinct CRSwNP endotype clusters, revealing that patients with mixed type 1/3 inflammation experience faster polyp recurrence than those with type…
Study Suggests Fovea-Disc Distance Length Factors into Scans for Glaucoma
Results indicate that FDD should be accounted for when measuring ganglion cell inner plexiform layer (GCIPL) in eyes with glaucoma.
Anemia
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
The HCPFive: Top News for Healthcare Providers from the Week of 04/13
Our top 5 headlines spotlight FDA approvals for maralixibat and dupilumab, plus key trial results in diabetes, cardiovascular disease, and retinal vein occlusion.
Obesity Increases Mortality, Complication Risk in Alcohol-Associated Hepatitis
Class 3 obesity conferred the greatest risk of mortality, complications, and higher resource utilization in alcohol-associated hepatitis hospitalizations.